Skip to content

Distance Education Versus Usual Care Qualification in Asthma Care

Distance Education Versus Usual Care in the Qualification of Asthma Care: A Cluster Randomized Clinical Trial - RESPIRANET

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01595971
Acronym
RESPIRANET
Enrollment
467
Registered
2012-05-10
Start date
2010-08-12
Completion date
2011-12-16
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Continuing education, Primary health care

Brief summary

The purpose of this study is to evaluate the effectiveness of multifaceted educational interventions in the care of asthma, conducted remotely over the platform TelessaúdeRS in teams of the Family Health Strategy and the consequent clinical improvement patients.

Detailed description

Cluster-randomized trial with follow-up of 6 months. The aim of this study is to determine whether multifaceted interventions performed at a distance for the care of asthma symptoms reduce overhead, improve asthma control and qualify the care provided to patients.

Interventions

Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.

OTHERusual care

Received the usual care provided

Sponsors

Federal University of Rio Grande do Sul
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
5 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Practice:Participate in the Telessaúde/RS. Minimal staff consisting of a general practitioner, nurse, nurse and community health agents (CHA), ability to give at least ten patients diagnosed with asthma, located in a municipality to make available for free inhaled medication (short-acting bronchodilators and corticosteroids ) for the treatment of asthma and willingness to participate in the study. * Patients: 5 to 45 years with a diagnosis of asthma made by a physician and register at least one consultation for asthma or an asthma-related hospitalization during the year preceding the beginning of the study.

Exclusion criteria

* Patients with other chronic diseases with pulmonary complications such as tuberculosis, cancer and cystic fibrosis or those with severe mental illness

Design outcomes

Primary

MeasureTime frameDescription
Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall.six monthsThe definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.

Secondary

MeasureTime frameDescription
Asthma control6 monthsControl of asthma will be evaluated by the excessive use of relief medication in the last month.
Health care utilization6 mesesProportion of unscheduled medical visits during the follow-up
Proportion of patients in use inhaled corticosteroids6 mesesUse of inhaled corticosteroids assessed by the proportion of patients who require medication to prevent asthma symptoms that are in use of inhaled corticosteroids.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026